questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
Oxidoreductases acting on CH-NH group donors
Oxidoreductases, (N-demethylating)
Oxidoreductases, (N-demethylating) : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Oxydoréductases
Déméthylation
Tests génétiques
Tests de métabolisme
Oxydoréductases
Enzymes
Réactions médicamenteuses
Dysfonctionnement enzymatique
Symptômes
Biomarqueurs
Oxydoréductases
Diagnostic
Tests sanguins
Métabolites
Diagnostic
Symptômes
5
Nausées
Réactions cutanées
Symptômes
Troubles neurologiques
Toxines
Symptômes
Effets secondaires
Médicaments
Déméthylation
Génétique
Environnement
Symptômes
Enfants
Troubles de l'attention
Symptômes
Prévention
5
Prévention
Médicaments
Déméthylation
Tests génétiques
Prévention
Risque
Éducation des patients
Médicaments
Prévention
Habitudes de vie
Fonction enzymatique
Prévention
Vaccinations
Infections
Prévention
Traitements
5
Traitements symptomatiques
Ajustements médicamenteux
Oxydoréductases
Suppléments
Antioxydants
Fonction enzymatique
Modifications alimentaires
Métabolisme
Oxydoréductases
Thérapie génique
Déficiences enzymatiques
Traitements
Médicaments
Effets indésirables
Ajustements
Complications
5
Complications
Réactions médicamenteuses
Dysfonctionnement
Complications
Traitement
Réversibilité
Qualité de vie
Complications
Symptômes chroniques
Surveillance
Ajustements de traitement
Prévention
Traitements
Complications
Allergies
Facteurs de risque
5
Facteurs de risque
Génétique
Environnement
Âge
Risque
Fonction enzymatique
Antécédents familiaux
Facteurs de risque
Troubles enzymatiques
Exposition
Toxines
Risque
Mode de vie
Complications
Prévention
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Oxidoreductases, (N-demethylating) : Questions médicales les plus fréquentes",
"headline": "Oxidoreductases, (N-demethylating) : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Oxidoreductases, (N-demethylating) : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-26",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Oxidoreductases, (N-demethylating)"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxidoreductases acting on CH-NH group donors",
"url": "https://questionsmedicales.fr/mesh/D000587",
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases acting on CH-NH group donors",
"code": {
"@type": "MedicalCode",
"code": "D000587",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aminopyrine N-demethylase",
"alternateName": "Aminopyrine N-Demethylase",
"url": "https://questionsmedicales.fr/mesh/D000633",
"about": {
"@type": "MedicalCondition",
"name": "Aminopyrine N-demethylase",
"code": {
"@type": "MedicalCode",
"code": "D000633",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.276"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydropteridine reductase",
"alternateName": "Dihydropteridine Reductase",
"url": "https://questionsmedicales.fr/mesh/D004093",
"about": {
"@type": "MedicalCondition",
"name": "Dihydropteridine reductase",
"code": {
"@type": "MedicalCode",
"code": "D004093",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.361"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dimethylglycine dehydrogenase",
"alternateName": "Dimethylglycine Dehydrogenase",
"url": "https://questionsmedicales.fr/mesh/D050893",
"about": {
"@type": "MedicalCondition",
"name": "Dimethylglycine dehydrogenase",
"code": {
"@type": "MedicalCode",
"code": "D050893",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.369"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ethylmorphine-N-demethylase",
"alternateName": "Ethylmorphine-N-Demethylase",
"url": "https://questionsmedicales.fr/mesh/D005037",
"about": {
"@type": "MedicalCondition",
"name": "Ethylmorphine-N-demethylase",
"code": {
"@type": "MedicalCode",
"code": "D005037",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Histone Demethylases",
"alternateName": "Histone Demethylases",
"url": "https://questionsmedicales.fr/mesh/D056466",
"about": {
"@type": "MedicalCondition",
"name": "Histone Demethylases",
"code": {
"@type": "MedicalCode",
"code": "D056466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.475"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sarcosine dehydrogenase",
"alternateName": "Sarcosine Dehydrogenase",
"url": "https://questionsmedicales.fr/mesh/D050892",
"about": {
"@type": "MedicalCondition",
"name": "Sarcosine dehydrogenase",
"code": {
"@type": "MedicalCode",
"code": "D050892",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.550"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases, (N-demethylating)",
"alternateName": "Oxidoreductases, N-Demethylating",
"code": {
"@type": "MedicalCode",
"code": "D010089",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christopher J Schofield",
"url": "https://questionsmedicales.fr/author/Christopher%20J%20Schofield",
"affiliation": {
"@type": "Organization",
"name": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, UK."
}
},
{
"@type": "Person",
"name": "Rajeev Ramanan",
"url": "https://questionsmedicales.fr/author/Rajeev%20Ramanan",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA."
}
},
{
"@type": "Person",
"name": "Sodiq O Waheed",
"url": "https://questionsmedicales.fr/author/Sodiq%20O%20Waheed",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA."
}
},
{
"@type": "Person",
"name": "Christo Z Christov",
"url": "https://questionsmedicales.fr/author/Christo%20Z%20Christov",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA."
}
},
{
"@type": "Person",
"name": "Samuel E Ross",
"url": "https://questionsmedicales.fr/author/Samuel%20E%20Ross",
"affiliation": {
"@type": "Organization",
"name": "Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Leukocytoclastic vasculitis as an adverse effect of propylthiouracil. A case report].",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37566757",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.29262/ram.v70i1.1210"
}
},
{
"@type": "ScholarlyArticle",
"name": "DRESS/DiHS syndrome induced by Propylthiouracil: a case report.",
"datePublished": "2023-01-23",
"url": "https://questionsmedicales.fr/article/36691013",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12902-023-01273-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of Propylthiouracil vs Methimazole for Thyroid Storm in Critically Ill Patients.",
"datePublished": "2023-04-03",
"url": "https://questionsmedicales.fr/article/37067797",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2023.8655"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hypertrophic Pachymeningitis Associated with Myeloperoxidase-anti-neutrophil Cytoplasmic Antibodies Induced by Propylthiouracil.",
"datePublished": "2022-11-16",
"url": "https://questionsmedicales.fr/article/36384900",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2169/internalmedicine.0692-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis.",
"datePublished": "2023-05-19",
"url": "https://questionsmedicales.fr/article/37205692",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0286097"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "Oxidoreductases acting on CH-NH group donors",
"item": "https://questionsmedicales.fr/mesh/D000587"
},
{
"@type": "ListItem",
"position": 6,
"name": "Oxidoreductases, (N-demethylating)",
"item": "https://questionsmedicales.fr/mesh/D010089"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Oxidoreductases, (N-demethylating) - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Oxidoreductases, (N-demethylating)",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Oxidoreductases, (N-demethylating)",
"description": "Comment diagnostiquer une déficience en oxydoréductases N-déméthylantes ?\nQuels tests sont utilisés pour évaluer l'activité enzymatique ?\nQuels symptômes peuvent indiquer un dysfonctionnement enzymatique ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Propylthiouracil#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Oxidoreductases, (N-demethylating)",
"description": "Quels symptômes sont associés à une altération de la déméthylation ?\nLes troubles neurologiques peuvent-ils être liés à ces enzymes ?\nComment les effets secondaires des médicaments sont-ils liés ?\nLes symptômes varient-ils selon les individus ?\nY a-t-il des symptômes spécifiques aux enfants ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Propylthiouracil#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Oxidoreductases, (N-demethylating)",
"description": "Comment prévenir les complications liées à la déméthylation ?\nY a-t-il des tests préventifs recommandés ?\nL'éducation des patients est-elle importante ?\nLes habitudes de vie peuvent-elles influencer la fonction enzymatique ?\nDes vaccinations peuvent-elles aider à prévenir des complications ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Propylthiouracil#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Oxidoreductases, (N-demethylating)",
"description": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?\nPeut-on utiliser des suppléments pour améliorer la fonction enzymatique ?\nLes modifications alimentaires peuvent-elles aider ?\nDes thérapies géniques sont-elles envisageables ?\nLes médicaments peuvent-ils être ajustés pour éviter des effets indésirables ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Propylthiouracil#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Oxidoreductases, (N-demethylating)",
"description": "Quelles complications peuvent survenir en cas de dysfonctionnement ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles être prévenues ?\nY a-t-il des complications spécifiques aux traitements ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Propylthiouracil#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Oxidoreductases, (N-demethylating)",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements enzymatiques ?\nL'âge joue-t-il un rôle dans le risque de dysfonctionnement ?\nLes antécédents familiaux sont-ils un facteur de risque ?\nL'exposition à des toxines peut-elle augmenter le risque ?\nLe mode de vie influence-t-il le risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Propylthiouracil#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en oxydoréductases N-déméthylantes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité enzymatique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de métabolisme des médicaments et des dosages enzymatiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un dysfonctionnement enzymatique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des réactions médicamenteuses inattendues peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains biomarqueurs peuvent indiquer une activité enzymatique altérée."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent mesurer les niveaux de métabolites spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une altération de la déméthylation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées, des vomissements et des réactions cutanées peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques peuvent-ils être liés à ces enzymes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en raison d'une accumulation de toxines."
}
},
{
"@type": "Question",
"name": "Comment les effets secondaires des médicaments sont-ils liés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une déméthylation inefficace peut entraîner des effets secondaires imprévus."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la génétique et de l'environnement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes plus aigus, comme des troubles de l'attention."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées à la déméthylation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les médicaments connus pour interférer avec la déméthylation peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests préventifs recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent être recommandés pour les personnes à risque."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les médicaments et leurs effets est crucial."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie peuvent-elles influencer la fonction enzymatique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie saines peuvent améliorer la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Des vaccinations peuvent-elles aider à prévenir des complications ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui compliquent les traitements."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements symptomatiques et des ajustements médicamenteux peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des suppléments pour améliorer la fonction enzymatique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments comme les antioxydants peuvent aider à soutenir la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les modifications alimentaires peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut soutenir le métabolisme et la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Des thérapies géniques sont-elles envisageables ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est une option potentielle pour corriger des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être ajustés pour éviter des effets indésirables ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ajuster les doses ou changer de médicament peut réduire les effets indésirables."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir en cas de dysfonctionnement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des réactions médicamenteuses graves peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en provoquant des symptômes chroniques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière et des ajustements de traitement peuvent prévenir les complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications spécifiques aux traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements peuvent entraîner des complications spécifiques, comme des allergies."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, environnementaux et liés au mode de vie peuvent influencer le risque."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque de dysfonctionnement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque peut augmenter avec l'âge en raison de la diminution de la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles enzymatiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines peut-elle augmenter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut affecter la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque de complications ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de complications liées à la déméthylation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, UK.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA.
Present address: Department of Chemistry, National Institute of Technology, Rourkela, Odisha, 769001, India.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.
St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney 22, Australia.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney 22, Australia.
Centro Andaluz de Biología del Desarrollo, CSIC-Universidad Pablo de Olavide-Junta de Andalucía, Seville, Spain.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India. baishnabtripathy@yahoo.com.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China; Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, China.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China; Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, China. Electronic address: echeung@um.edu.mo.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China; Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China. Electronic address: andrewh@sustech.edu.cn.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.
Publications dans "Oxidoreductases, (N-demethylating)" :
The most common cause of hyperthyroidism is Graves' disease. Propylthiouracil (PTU) is one of the drugs used to treat this disease. Leukocytoclastic vasculitis is described among dermatologic adverse ...
A 18-year-old woman, allergic to methimazole, developed a vasculitis associated to ANCAs with characteristics of leukocytoclastic vasculitis, associated to PTU treatment. She did not present systemic ...
Leukocytoclastic vasculitis should be considered in the spectrum of complications caused by the consumption of propylthiouracil. The lesions can manifest over time, from a few weeks to years after tak...
Drug reaction with eosinophilia and systemic symptoms (DRESS), also known as Drug-induced hypersensitivity syndrome (DiHS), is a severe adverse drug reaction. Propylthiouracil, a member of thiouracils...
A 38-year-old female was treated with methimazole for hyperthyroidism at first. 4 weeks later, the patient developed elevated liver transaminase so methimazole was stopped. After liver function improv...
Propylthiouracil is a rare cause of the DRESS/DiHS syndrome, which typically consists of severe dermatitis and various degrees of internal organ involvement. We want to emphasize through this severe c...
Thyroid storm is the most severe form of thyrotoxicosis, with high mortality, and is treated with propylthiouracil and methimazole. Some guidelines recommend propylthiouracil over methimazole, althoug...
To compare outcomes associated with use of propylthiouracil vs methimazole for the treatment of thyroid storm....
This comparative effectiveness study comprised a large, multicenter, US-based cohort from the Premier Healthcare Database between January 1, 2016, and December 31, 2020. It included 1383 adult patient...
Patients received either propylthiouracil or methimazole for treatment of thyroid storm. Exposure was assigned based on the initial thionamide administered....
The primary outcome was the adjusted risk difference of in-hospital death or discharge to hospice between patients treated with propylthiouracil and those treated with methimazole, assessed by targete...
A total of 1383 patients (656 [47.4%] treated with propylthiouracil; mean [SD] age, 45 [16] years; 473 women [72.1%]; and 727 [52.6%] treated with methimazole; mean [SD] age, 45 [16] years; 520 women ...
In this comparative effectiveness study of a multicenter cohort of adult patients with thyroid storm, no significant differences were found in mortality or adverse events in patients who were treated ...
A 71-year-old man with hyperthyroidism complained of headache lasting two months. He had been using propylthiouracil (PTU) for 14 years. Treatment intensification did not improve the symptoms. Blood t...
The purpose of this meta-analysis was to assess the safety of the anti-thyroid drugs (ATDs) propylthiouracil (PTU) and methimazole (MMI) in the treatment of hyperthyroidism during pregnancy....
From inception until June 2, 2022, all available studies were searched in PubMed, Web of Science, Cochrane, EBSCO, Embase, Scopus, and CNKI....
Thirteen articles satisfying the inclusion criteria were examined. Our meta-analysis indicated that pregnant women treated with MMI had a higher risk of congenital anomalies than those treated with PT...
The study confirmed propylthiouracil is a safer alternative to methimazole for treating hyperthyroidism in pregnant women, and it is appropriate to treat maternal thyroid disease with PTU during the f...
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is an autoimmune condition characterized by necrotizing inflammation of small vessels throughout the body. Pharmaceutical agents have ...
The use of propylthiouracil (PTU) is associated with the development of autoantibodies, namely, antineutrophil cytoplasmic antibodies (ANCAs), which are associated with the pathogenesis of ANCA-associ...
We present a case of neonatal goiter caused by exposure to propylthiouracil (PTU) during pregnancy in this case report. The mother was treated with PTU while pregnant and had a history of Graves' illn...
Hyperthyroidism is more common in women and the sensitivity of thyroid function changes during pregnancy. Excess levels of thyroid hormones and thioamides have a major impact on maternal and fetal out...
Agranulocytosis is a serious adverse effect of methimazole (MMI) and propylthiouracil (PTU), and although there have been reports suggesting a dose-dependent incidence in relation to both drugs, the e...